| Amgen Switzerland AG - Neupogen Amgen 30, Injektionslösung in einer Fertigspritze |
| 51035 | | 06 | | Neupogen Amgen 30 | | Injektionslösung in einer Fertigspritze | | L03AA02 | | Filgrastim | | 27.11.1998 | | |
|
| Composition |
| filgrastimum 30 Mio. U., acidum aceticum glaciale, natrii hydroxidi solutio 18% m/m corresp. natrium 15.9 µg, polysorbatum 80, sorbitolum 25 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Filgrastim | 30Mio. U. / 0.5ml |
| | BAG: Active Agent | Dose |
|---|
| Filgrastimum Adnr | 30 Mio U |
| | | | Inactive agents |
|---|
| Sodium Acetate Trihydrate | | Polysorbatum 80 | | Sorbitol |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 186 | 5 1 syringe(s) à 0.5 ml | 345.86 | 388.70 | A | SL | Yes |
|
